Assessment of current follow-up for complete molar pregnancies: A single centre review
- PMID: 33034043
- DOI: 10.1111/ajo.13258
Assessment of current follow-up for complete molar pregnancies: A single centre review
Abstract
Background: Current guidelines recommend that resolution of a complete molar pregnancy (CMP) can only be confirmed once a negative β-human chorionic gonadotropin (β-hCG) has been maintained for six months following uterine surgical evacuation. However, multiple studies have found that the risk of developing gestational trophoblastic neoplasia (GTN) once a negative β-hCG had been obtained is negligible, which suggests that a shorter follow-up may be reasonable.
Aim: To determine the trend in β-hCG following diagnosis of a CMP and the incidence of GTN, in a single unit.
Materials and methods: All patients presenting to the tertiary hospital, Royal Prince Alfred Hospital Early Pregnancy Assessment Service (RPAH EPAS), with a histopathological diagnosis of a CMP between 2010 and 2017 were included. Data collected included age, parity, β-hCG at diagnosis, subsequent β-hCG levels, incidence of GTN and treatment required.
Results: Sixty-seven patients were diagnosed with CMP between January 2010 and July 2017 through RPAH EPAS. The mean age of women diagnosed with a CMP was 33 years. None of the 40 patients who spontaneously achieved a negative β-hCG and completed their six months follow-up had a subsequent rise in β-hCG. The median number of days from surgical evacuation to normalisation of β-hCG was 55.5 days. Sixteen out of 67 patients who had a CMP required further management for persistent GTN. None of these patients achieved a negative β-hCG prior to further management.
Conclusions: Consideration could be made to decreasing the period of β-hCG monitoring for women who achieve a spontaneous negative β-hCG following surgical evacuation of a CMP.
Keywords: complete molar pregnancy; follow-up; gestational trophoblastic disease; gestational trophoblastic neoplasia; treatment.
© 2020 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
References
-
- Duggan P, Leung Y, Neesham D et al. Management of Gestational Trophoblastic Disease: RANZCOG Statement, 2017.
-
- Coyle C, Short D, Jackson L et al. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients. Gynecol Oncol 2018; 148: 254-257.
-
- Royal College of Obstetricians and Gynaecologists. The Management of Gestational Trophoblastic Disease, Green-top Guideline No. 38, 2010.
-
- New Zealand Gynaecologic Cancer Group. Gestational Trophoblastic Disease. Wellington: Ministry of Health; 2018.
-
- Kerkmeijer L, Wielsma S, Wiesma S et al. Guidelines following hydatidiform mole: a reappraisal. Aust N Z J Obstet Gynaecol 2006; 46: 112-118.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
